Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,116
Closed -$405K 86
2025
Q2
$405K Sell
5,116
-382
-7% -$30.4K 0.33% 84
2025
Q1
$494K Sell
5,498
-702
-11% -$65.5K 0.37% 86
2024
Q4
$617K Sell
6,200
-182
-3% -$18.8K 0.45% 66
2024
Q3
$725K Buy
6,382
+62
+1% +$7.37K 0.53% 60
2024
Q2
$782K Sell
6,320
-43
-0.7% -$5.54K 0.71% 42
2024
Q1
$840K Buy
6,363
+54
+0.9% +$6.66K 1.63% 13
2023
Q4
$688K Hold
6,309
1.46% 22
2023
Q3
$650K Buy
6,309
+10
+0.2% +$1.08K 1.53% 21
2023
Q2
$727K Sell
6,299
-3,390
-35% -$385K 0.7% 36
2023
Q1
$1.03M Sell
9,689
-304
-3% -$32.8K 2.52% 8
2022
Q4
$1.11M Buy
+9,993
New +$1.02M 2.56% 9

Other funds holding MRK

Prossimo Advisors's MRK Position: Q3 2025 in Review

Prossimo Advisors sold out of Merck (MRK) in Q3 2025, closing a stake of 5,116 shares — an estimated $405K sold.

Prossimo Advisors first reported a position in MRK in Q4 2022 and held it in 11 quarters. The position peaked at $1.11M in Q4 2022. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Prossimo Advisors reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Prossimo Advisors sold 5,116 Merck shares in Q3 2025, an estimated $405K.
  • Prossimo Advisors first reported a position in Merck in Q4 2022 and held it in 11 quarters.
  • Prossimo Advisors's Merck position peaked at $1.11M in Q4 2022.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Prossimo Advisors's 13F filing for Q3 2025, filed 28 Oct 2025.